Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3626587 | 1.00 | PTPRC (0.57) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL1152 | 1.00 | PTPRC (0.57) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL273663 | 1.00 | PTPRC (0.57) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| Phosphoric Acid SCHEMBL27545043 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| Phosphine SCHEMBL28192584 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL29567635 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| Phosphoric Acid SCHEMBL3476886 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL19615883 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL29613927 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL27947556 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024197259-A1 | TRANSCYTOTIC INTERCELLULAR GELATION ENABLES CELL SPHEROIDS | BRANDEIS UNIVERSITY (US) | 2024-09-26 | — | — | WO | claimed |
| EP-1501938-B1 | ANALYSIS OF SUBSTRATE UTILIZATION BY ANIMAL OR PLANT CELLS | BIOLOG INC (US) | 2009-10-21 | — | — | EP | claimed |
| US-6727076-B2 | UTILIZES A GEL FORMING MATRIX FOR THE RAPID SCREENING OF CLINICAL AND ENVIRONMENTAL CULTURES | BIOLOG, INC. | 2004-04-27 | — | — | US | claimed |
| US-6472201-B1 | GROWING AND TESTING MICROORGANISMS IN A MULTITEST FORMAT WHICH UTILIZES A GEL FORMING MATRIX FOR THE RAPID SCREENING OF CLINICAL AND ENVIRONMENTAL CULTURES | BIOLOG, INC. | 2002-10-29 | — | — | US | claimed |
| US-5767158-A | FOR BLEACHING SKIN | SHISEIDO CO., LTD. (JP) | 1998-06-16 | — | — | US | claimed |
| EP-4673162-A1 | PATHOGEN-SPECIFIC PEPTIDE TO BLOCK VIRULENCE-RELATED SIGNALING IN CANDIDA ALBICANS | I3S - Instituto de Investigação e Inovação em Saúde, Associação (PT) | 2026-01-07 | — | — | EP | disclosed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250206776-A1 | ENZYME-INSTRUCTED SELF-ASSEMBLY OF PEPTIDES CONTAINING N-TERMINAL PHOSPHO-AROMATIC CAPPING MOTIF, AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2025-06-26 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| US-12239142-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-03-04 | — | — | US | disclosed |
| WO-2024197259-A1 | TRANSCYTOTIC INTERCELLULAR GELATION ENABLES CELL SPHEROIDS | BRANDEIS UNIVERSITY (US) | 2024-09-26 | — | — | WO | disclosed |
| WO-2024181880-A1 | PATHOGEN-SPECIFIC PEPTIDE TO BLOCK VIRULENCE-RELATED SIGNALING IN CANDIDA ALBICANS | I3S - INSTITUTO DE INVESTIGAÇÃO E INOVAÇÃO EM SAÚDE, ASSOCIAÇÃO (PT) | 2024-09-06 | — | — | WO | disclosed |
| US-20030148413-A1 | Comparative phenotype analysis | BIOLOG, INC. (CA) | 2003-08-07 | — | — | US | disclosed |
| US-6472201-B1 | GROWING AND TESTING MICROORGANISMS IN A MULTITEST FORMAT WHICH UTILIZES A GEL FORMING MATRIX FOR THE RAPID SCREENING OF CLINICAL AND ENVIRONMENTAL CULTURES | BIOLOG, INC. | 2002-10-29 | — | — | US | disclosed |
| US-20020110848-A1 | Comparative phenotype analysis | BIOLOG, INC. | 2002-08-15 | — | — | US | disclosed |
| US-6387651-B1 | PREPARING SUSPENSIONS OF EACH CELL PREPARATION, PLACING SUSPENSIONS INTO TESTING DEVICE, DETECTING RESPONSE OF CELL PREPARATIONS TO AT LEAST ONE TEST SUBSTRATE, AND COMPARING RESPONSES | BIOLOG, INC. | 2002-05-14 | — | — | US | disclosed |
| EP-1088097-A1 | COMPARATIVE PHENOTYPE ANALYSIS | BIOLOG, INC. (US) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999066066-A1 | COMPARATIVE PHENOTYPE ANALYSIS | BIOLOG, INC. (US) | 1999-12-23 | — | — | WO | disclosed |
| US-5767158-A | FOR BLEACHING SKIN | SHISEIDO CO., LTD. (JP) | 1998-06-16 | — | — | US | disclosed |
| EP-0728469-A2 | An endermic liniment | SHISEIDO COMPANY LIMITED (JP) | 1996-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250206776-A1 | ENZYME-INSTRUCTED SELF-ASSEMBLY OF PEPTIDES CONTAINING N-TERMINAL PHOSPHO-AROMATIC CAPPING MOTIF, AND USES THEREOF | ANPEP, DNPEP, PTMS | PTPRC 81/4885SLC7A5 2976/4885PTPN1 97/4885 |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | PTPRC 2138/4885SLC7A5 3048/4885PTPN1 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.